{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:38:49Z","timestamp":1790779129176,"version":"4.1.0"},"reference-count":251,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00771","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T04:18:22Z","timestamp":1555561102000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":210,"title":["Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression"],"prefix":"10.3389","volume":"10","author":[{"given":"Antonino","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Mortara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Baci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J Cell Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10555-007-9108-5","article-title":"Inflammation, inflammatory cells and angiogenesis: decisions and indecisions","volume":"27","author":"Noonan","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fimmu.2018.00527","article-title":"Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy","volume":"9","author":"Albini","year":"2018","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1158\/0008-5472.CAN-15-1502","article-title":"Plasticity beyond cancer cells and the \u201cimmunosuppressive switch\u201d","volume":"75","author":"Granot","year":"2015","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrc3498","article-title":"Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?","volume":"13","author":"Holzel","year":"2013","journal-title":"Nat Rev Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","article-title":"Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression","volume":"22","author":"Ostrand-Rosenberg","year":"2012","journal-title":"Semin Cancer Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","article-title":"Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response","volume":"179","author":"Sinha","year":"2007","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.coi.2018.03.015","article-title":"Plasticity and biological diversity of myeloid derived suppressor cells","volume":"51","author":"Ben-Meir","year":"2018","journal-title":"Curr Opin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br J Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00281-016-0597-6","article-title":"Myeloid-derived suppressor cells and tumor escape from immune surveillance","volume":"39","author":"Umansky","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fimmu.2013.00490","article-title":"The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity","volume":"4","author":"Baginska","year":"2013","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2438598","DOI":"10.1155\/2018\/2438598","article-title":"Natural killer cells from malignant pleural effusion are endowed with a decidual-like proangiogenic polarization","volume":"2018","author":"Bosi","year":"2018","journal-title":"J Immunol Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"dju200","DOI":"10.1093\/jnci\/dju200","article-title":"A think tank of TINK\/TANKs: tumor-infiltrating\/tumor-associated natural killer cells in tumor progression and angiogenesis","volume":"106","author":"Bruno","year":"2014","journal-title":"J Natl Cancer Inst."},{"key":"B18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1158\/2159-8290.CD-15-0732","article-title":"STAT5 is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion","volume":"6","author":"Gotthardt","year":"2016","journal-title":"Cancer Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.18632\/oncotarget.3453","article-title":"Characterization of tumor infiltrating natural killer cell subset","volume":"6","author":"Levi","year":"2015","journal-title":"Oncotarget."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3389\/fimmu.2018.02776","article-title":"The Yin and Yang of myeloid derived suppressor cells","volume":"9","author":"Budhwar","year":"2018","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e954829","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"Oncoimmunology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J Autoimmun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1182\/blood-2003-08-2820","article-title":"Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production","volume":"104","author":"Chalifour","year":"2004","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4049\/jimmunol.1003593","article-title":"Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release","volume":"187","author":"Bouzani","year":"2011","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.chom.2013.09.007","article-title":"The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients","volume":"14","author":"Li","year":"2013","journal-title":"Cell Host Microbe."},{"key":"B30","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.148.9.2953","article-title":"Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation","volume":"148","author":"Murphy","year":"1992","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2011","journal-title":"Nature."},{"key":"B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/mi.2012.49","article-title":"IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection","volume":"6","author":"Kumar","year":"2013","journal-title":"Mucosal Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.4049\/jimmunol.1301889","article-title":"CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph","volume":"192","author":"Carrega","year":"2014","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of Metastasis by NK Cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4218254","DOI":"10.1155\/2017\/4218254","article-title":"Natural killer cells in the orchestration of chronic inflammatory diseases","volume":"2017","author":"Parisi","year":"2017","journal-title":"J Immunol Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0065-230X(03)90004-2","article-title":"Natural killer cells and cancer","volume":"90","author":"Wu","year":"2003","journal-title":"Adv Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/505483e","article-title":"Immunotherapy: natural killers take on cancer","volume":"505","author":"Zimmer","year":"2014","journal-title":"Nature."},{"key":"B39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1593\/neo.121758","article-title":"The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer","volume":"15","author":"Bruno","year":"2013","journal-title":"Neoplasia."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1096\/fj.201701103R","article-title":"Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer","volume":"32","author":"Bruno","year":"2018","journal-title":"FASEB J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00262-015-1782-5","article-title":"Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study","volume":"65","author":"Mandruzzato","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"aaf8943","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional regulation of myeloid-derived suppressor cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J Leukoc Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-014-1639-3","article-title":"Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy","volume":"64","author":"Messmer","year":"2015","journal-title":"Cancer Immunol Immunother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nyas.12469","article-title":"Myeloid-derived suppressor cell heterogeneity in human cancers","volume":"1319","author":"Solito","year":"2014","journal-title":"Ann N Y Acad Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0164514","DOI":"10.1371\/journal.pone.0164514","article-title":"The role of myeloid-derived suppressor cells in patients with solid tumors: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","article-title":"Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells","volume":"166","author":"Gabrilovich","year":"2001","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/blood-2003-01-0190","article-title":"Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB\/c mice suppresses immune reactivity","volume":"102","author":"Melani","year":"2003","journal-title":"Blood."},{"key":"B50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3109\/08820139.2012.673191","article-title":"Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship","volume":"41","author":"Monu","year":"2012","journal-title":"Immunol Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1182\/blood-2010-11-317321","article-title":"Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells","volume":"117","author":"Hoechst","year":"2011","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1182\/blood-2006-09-046201","article-title":"Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host","volume":"109","author":"Liu","year":"2007","journal-title":"Blood."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/eji.200939910","article-title":"TGF-beta affects development and differentiation of human natural killer cell subsets","volume":"40","author":"Allan","year":"2010","journal-title":"Eur J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.4049\/jimmunol.1202582","article-title":"Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors","volume":"190","author":"Cerdeira","year":"2013","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1073\/pnas.0611098104","article-title":"TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16\u2212 NK cells with similarities to decidual NK cells","volume":"104","author":"Keskin","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"15563","DOI":"10.1073\/pnas.0507835102","article-title":"Human decidual NK cells form immature activating synapses and are not cytotoxic","volume":"102","author":"Kopcow","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B59","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol."},{"key":"B60","unstructured":"Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicitye1431082 TaiLH AlkayyalAA LeslieAL SahiS BennettS Tanese de SouzaC 10.1080\/2162402X.2018.143108229872554Oncoimmunology.72018"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1182\/blood-2007-07-100404","article-title":"A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression","volume":"111","author":"Vaknin","year":"2008","journal-title":"Blood."},{"key":"B62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1182\/blood-2008-03-143776","article-title":"Mononuclear myeloid-derived \u201csuppressor\u201d cells express RAE-1 and activate natural killer cells","volume":"112","author":"Nausch","year":"2008","journal-title":"Blood."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","article-title":"Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche","volume":"72","author":"Sceneay","year":"2012","journal-title":"Cancer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"37931","DOI":"10.18632\/oncotarget.9270","article-title":"Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma","volume":"7","author":"Binsfeld","year":"2016","journal-title":"Oncotarget."},{"key":"B66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","article-title":"Regulation of tumor metastasis by myeloid-derived suppressor cells","volume":"66","author":"Condamine","year":"2015","journal-title":"Annu Rev Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J Clin Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.4049\/jimmunol.1200584","article-title":"NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells","volume":"189","author":"Fortin","year":"2012","journal-title":"J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","article-title":"Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells","volume":"73","author":"Tai","year":"2013","journal-title":"Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"18081787","DOI":"10.3390\/ijms18081787","article-title":"Dysfunctional natural killer cells in the aftermath of cancer surgery","volume":"18","author":"Angka","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0955-0674(00)00199-X","article-title":"The Stat family in cytokine signaling","volume":"13","author":"Ihle","year":"2001","journal-title":"Curr Opin Cell Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.4049\/jimmunol.1102913","article-title":"Cytokine signaling: birth of a pathway","volume":"187","author":"O'Shea","year":"2011","journal-title":"J Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N Engl J Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"Thomas","year":"2015","journal-title":"Br J Cancer."},{"key":"B77","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"B78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4137\/IJTR.S4157","article-title":"IDO-mediated tryptophan degradation in the pathogenesis of malignant tumor disease","volume":"3","author":"Sucher","year":"2010","journal-title":"Int J Tryptophan Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.4049\/jimmunol.1400833","article-title":"Noncanonical NF-kappaB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer","volume":"193","author":"Yu","year":"2014","journal-title":"J Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1535-7163.MCT-12-1087","article-title":"Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression","volume":"12","author":"Sun","year":"2013","journal-title":"Mol Cancer Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.4049\/jimmunol.1302389","article-title":"NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma","volume":"193","author":"Sui","year":"2014","journal-title":"J Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3389\/fimmu.2016.00694","article-title":"STATs in NK-cells: the good, the bad, and the ugly","volume":"7","author":"Gotthardt","year":"2016","journal-title":"Front Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrc1926","article-title":"Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer","volume":"6","author":"Bierie","year":"2006","journal-title":"Nat Rev Cancer."},{"key":"B85","doi-asserted-by":"publisher","first-page":"381428","DOI":"10.5402\/2012\/381428","article-title":"The dual role of TGFbeta in human cancer: from tumor suppression to cancer metastasis","volume":"2012","author":"Lebrun","year":"2012","journal-title":"ISRN Mol Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell."},{"key":"B87","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24293","article-title":"IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity","volume":"551","author":"Molgora","year":"2017","journal-title":"Nature."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3389\/fimmu.2018.02506","article-title":"The pro-tumorigenic IL-33 involved in antitumor immunity: a Yin and Yang cytokine","volume":"9","author":"Fournie","year":"2018","journal-title":"Front Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.3389\/fimmu.2018.03051","article-title":"Interleukin-33 in malignancies: friends or foes?","volume":"9","author":"Shen","year":"2018","journal-title":"Front Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1477-7819-11-118","article-title":"Nitric oxide and cancer: a review","volume":"11","author":"Choudhari","year":"2013","journal-title":"World J Surg Oncol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-06-2149","article-title":"An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer","volume":"67","author":"Ying","year":"2007","journal-title":"Cancer Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-17-0691","article-title":"Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing Fc receptor-mediated natural killer cell function","volume":"24","author":"Stiff","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B93","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood.V93.11.3876","article-title":"Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production","volume":"93","author":"Cifone","year":"1999","journal-title":"Blood."},{"key":"B94","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.163.3.1473","article-title":"Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha","volume":"163","author":"Furuke","year":"1999","journal-title":"J Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity","volume":"23","author":"Harris","year":"2002","journal-title":"Trends Immunol."},{"key":"B96","first-page":"293","article-title":"[Computed tomography of the skeletal system]","volume":"43","author":"Maas","year":"1990","journal-title":"Rontgenpraxis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat Rev Cancer."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1158\/1078-0432.CCR-14-0635","article-title":"Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity","volume":"20","author":"Mao","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.celrep.2017.08.098","article-title":"Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1\/mPGES-1-derived prostaglandin E2","volume":"20","author":"Newson","year":"2017","journal-title":"Cell Rep."},{"key":"B100","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrc2639","article-title":"Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?","volume":"9","author":"Lob","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"B101","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"E231","DOI":"10.1073\/pnas.1206322110","article-title":"Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface","volume":"110","author":"Fu","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B103","doi-asserted-by":"publisher","first-page":"7752","DOI":"10.4049\/jimmunol.0901004","article-title":"Human activated T lymphocytes modulate IDO expression in tumors through Th1\/Th2 balance","volume":"183","author":"Godin-Ethier","year":"2009","journal-title":"J Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1517\/14728222.2014.995092","article-title":"The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment","volume":"19","author":"Gostner","year":"2015","journal-title":"Expert Opin Ther Targets."},{"key":"B105","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2018.00151","article-title":"The role of indoleamine-2,3-dioxygenase in cancer development, diagnostics, and therapy","volume":"9","author":"Hornyak","year":"2018","journal-title":"Front Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molimm.2018.09.011","article-title":"IDO1 impairs NK cell cytotoxicity by decreasing NKG2D\/NKG2DLs via promoting miR-18a","volume":"103","author":"Zhang","year":"2018","journal-title":"Mol Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood."},{"key":"B109","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","article-title":"Immunosuppressive activities of adenosine in cancer","volume":"29","author":"Allard","year":"2016","journal-title":"Curr Opin Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer."},{"key":"B111","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.4049\/jimmunol.1400578","article-title":"Role of TGF-beta signaling in generation of CD39+CD73+ myeloid cells in tumors","volume":"193","author":"Ryzhov","year":"2014","journal-title":"J Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1385\/IR:36:1:91","article-title":"Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2\/NKp46-activated NK cells: involvement of protein kinase A isozyme I (PKA I)","volume":"36","author":"Raskovalova","year":"2006","journal-title":"Immunol Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4049\/jimmunol.1500591","article-title":"CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation","volume":"195","author":"Morandi","year":"2015","journal-title":"J Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1158\/0008-5472.CAN-13-3583","article-title":"Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment","volume":"74","author":"Cekic","year":"2014","journal-title":"Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jri.2010.11.002","article-title":"Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells","volume":"88","author":"Blois","year":"2011","journal-title":"J Reprod Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/humrep\/deu017","article-title":"Increased angiogenic factor secretion by decidual natural killer cells from pregnancies with high uterine artery resistance alters trophoblast function","volume":"29","author":"Wallace","year":"2014","journal-title":"Hum Reprod."},{"key":"B119","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1189\/jlb.0406250","article-title":"Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy","volume":"80","author":"Lash","year":"2006","journal-title":"J Leukoc Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/humrep\/den408","article-title":"Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy","volume":"24","author":"Naruse","year":"2009","journal-title":"Hum Reprod."},{"key":"B121","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/molehr\/gar033","article-title":"Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases","volume":"17","author":"Anacker","year":"2011","journal-title":"Mol Hum Reprod."},{"key":"B122","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000456033","article-title":"Human birth weight and reproductive immunology: testing for interactions between maternal and offspring KIR and HLA-C genes","volume":"81","author":"Clark","year":"2016","journal-title":"Hum Hered."},{"key":"B123","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00251-017-1003-9","article-title":"The role of KIR and HLA interactions in pregnancy complications","volume":"69","author":"Colucci","year":"2017","journal-title":"Immunogenetics."},{"key":"B124","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jri.2016.09.002","article-title":"The role of decidual NK cells in pregnancies with impaired vascular remodelling","volume":"119","author":"Cartwright","year":"2017","journal-title":"J Reprod Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/eji.201344200","article-title":"Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses","volume":"44","author":"Kostlin","year":"2014","journal-title":"Eur J Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/aji.12351","article-title":"Reduced myeloid-derived suppressor cells in the blood and endometrium is associated with early miscarriage","volume":"73","author":"Nair","year":"2015","journal-title":"Am J Reprod Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nri3017","article-title":"Tumour immunology: MDSCs come at a cost","volume":"11","author":"Papatriantafyllou","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jri.2018.05.002","article-title":"Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia","volume":"127","author":"Wang","year":"2018","journal-title":"J Reprod Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1002\/jcp.26075","article-title":"Myeloid-derived suppressor cells: important contributors to tumor progression and metastasis","volume":"233","author":"Safarzadeh","year":"2018","journal-title":"J Cell Physiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00262-016-1849-y","article-title":"Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy","volume":"65","author":"Baniyash","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell."},{"key":"B134","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1172\/JCI35213","article-title":"Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice","volume":"118","author":"Kujawski","year":"2008","journal-title":"J Clin Invest."},{"key":"B135","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat Rev Cancer."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e998519","DOI":"10.1080\/2162402X.2014.998519","article-title":"Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells","volume":"4","author":"Karakhanova","year":"2015","journal-title":"Oncoimmunology."},{"key":"B137","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/CJI.0b013e3182619c8e","article-title":"TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis","volume":"35","author":"Guedez","year":"2012","journal-title":"J Immunother."},{"key":"B138","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccr.2007.12.004","article-title":"Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis","volume":"13","author":"Yang","year":"2008","journal-title":"Cancer Cell."},{"key":"B139","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2015.00004","article-title":"The regulation of MMP targeting to invadopodia during cancer metastasis","volume":"3","author":"Jacob","year":"2015","journal-title":"Front Cell Dev Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"27478","DOI":"10.18632\/oncotarget.4393","article-title":"Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model","volume":"6","author":"Sorrentino","year":"2015","journal-title":"Oncotarget."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1593\/neo.131748","article-title":"Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma","volume":"15","author":"Iannone","year":"2013","journal-title":"Neoplasia."},{"key":"B142","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.4049\/jimmunol.1103553","article-title":"Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release","volume":"188","author":"Jayaraman","year":"2012","journal-title":"J Immunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1158\/1078-0432.CCR-16-0387","article-title":"Expression of vascular endothelial growth factor in ovarian cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells","volume":"23","author":"Horikawa","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fonc.2014.00070","article-title":"Control of the immune response by pro-angiogenic factors","volume":"4","author":"Voron","year":"2014","journal-title":"Front Oncol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3389\/fimmu.2018.00978","article-title":"Targeting VEGF\/VEGFR to modulate antitumor immunity","volume":"9","author":"Yang","year":"2018","journal-title":"Front Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","article-title":"Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype","volume":"14","author":"Piao","year":"2012","journal-title":"Neuro Oncol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.2147\/OTT.S112242","article-title":"Sunitinib: the antiangiogenic effects and beyond","volume":"9","author":"Hao","year":"2016","journal-title":"Onco Targets Ther."},{"key":"B148","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.intimp.2011.01.030","article-title":"MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy","volume":"11","author":"Finke","year":"2011","journal-title":"Int Immunopharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MOH.0b013e3283386660","article-title":"Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis","volume":"17","author":"Ferrara","year":"2010","journal-title":"Curr Opin Hematol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"CCL2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function","volume":"12","author":"Chun","year":"2015","journal-title":"Cell Rep."},{"key":"B151","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-15-2463","article-title":"Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs)","volume":"22","author":"Alfaro","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e18534","DOI":"10.1371\/journal.pone.0018534","article-title":"Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1","volume":"6","author":"Boelte","year":"2011","journal-title":"PLoS ONE."},{"key":"B154","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jbo.2018.01.002","article-title":"Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer","volume":"11","author":"Wang","year":"2018","journal-title":"J Bone Oncol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nature06348","article-title":"Bv8 regulates myeloid-cell-dependent tumour angiogenesis","volume":"450","author":"Shojaei","year":"2007","journal-title":"Nature."},{"key":"B156","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1073\/pnas.0902280106","article-title":"G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models","volume":"106","author":"Shojaei","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B157","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.1074\/jbc.M113.450049","article-title":"G-protein-coupled receptor agonist BV8\/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells","volume":"288","author":"Xin","year":"2013","journal-title":"J Biol Chem."},{"key":"B158","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/mc.22767","article-title":"Inhibition of JAK2\/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer","volume":"57","author":"Liu","year":"2018","journal-title":"Mol Carcinog."},{"key":"B159","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1073\/pnas.1320243111","article-title":"Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8","volume":"111","author":"Ahn","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B160","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology."},{"key":"B161","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4049\/jimmunol.181.1.346","article-title":"Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma","volume":"181","author":"Kusmartsev","year":"2008","journal-title":"J Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2051-1426-1-10","article-title":"Myeloid derived suppressor cells\u2014a new therapeutic target in the treatment of cancer","volume":"1","author":"Wesolowski","year":"2013","journal-title":"J Immunother Cancer."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1158\/0008-5472.CAN-14-0301","article-title":"Chemotherapeutic targeting of cancer-induced immunosuppressive cells","volume":"74","author":"Alizadeh","year":"2014","journal-title":"Cancer Res."},{"key":"B164","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","article-title":"Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity","volume":"11","author":"Suzuki","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2217\/imt-2017-0046","article-title":"PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo","volume":"9","author":"Kuroda","year":"2017","journal-title":"Immunotherapy."},{"key":"B166","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1189\/jlb.0813435","article-title":"DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment","volume":"95","author":"Mikyskova","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1158\/1078-0432.CCR-10-0733","article-title":"A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers","volume":"16","author":"Kodumudi","year":"2010","journal-title":"Clin Cancer Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/1547691X.2011.642418","article-title":"Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner","volume":"9","author":"Michels","year":"2012","journal-title":"J Immunotoxicol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","article-title":"5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity","volume":"70","author":"Vincent","year":"2010","journal-title":"Cancer Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/0008-5472.CAN-13-1545","article-title":"Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer","volume":"74","author":"Alizadeh","year":"2014","journal-title":"Cancer Res."},{"key":"B171","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/bjc.2013.695","article-title":"Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms","volume":"110","author":"Gujar","year":"2014","journal-title":"Br J Cancer."},{"key":"B172","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.intimp.2009.03.015","article-title":"Gemcitabine directly inhibits myeloid derived suppressor cells in BALB\/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice","volume":"9","author":"Le","year":"2009","journal-title":"Int Immunopharmacol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"29964","DOI":"10.1074\/jbc.M115.674010","article-title":"Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6","volume":"290","author":"Cao","year":"2015","journal-title":"J Biol Chem."},{"key":"B174","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.canlet.2016.01.017","article-title":"Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals","volume":"373","author":"Shi","year":"2016","journal-title":"Cancer Lett."},{"key":"B175","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3945\/jn.108.100198","article-title":"Markers of innate immune function are associated with vitamin a stores in men","volume":"139","author":"Ahmad","year":"2009","journal-title":"J Nutr."},{"key":"B176","doi-asserted-by":"publisher","first-page":"e998107","DOI":"10.1080\/2162402X.2014.998107","article-title":"Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model","volume":"4","author":"Du Four","year":"2015","journal-title":"Oncoimmunology."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00262-015-1735-z","article-title":"Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma","volume":"64","author":"Guislain","year":"2015","journal-title":"Cancer Immunol Immunother."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-08-1332","article-title":"Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients","volume":"15","author":"Ko","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B179","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1158\/0008-5472.CAN-08-4709","article-title":"The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies","volume":"69","author":"Ozao-Choy","year":"2009","journal-title":"Cancer Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1158\/0008-5472.CAN-15-1490","article-title":"Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor-bearing hosts by ibrutinib treatment","volume":"76","author":"Stiff","year":"2016","journal-title":"Cancer Res."},{"key":"B181","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","article-title":"Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells","volume":"69","author":"Xin","year":"2009","journal-title":"Cancer Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J Immunother Cancer."},{"key":"B183","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00432-010-0944-2","article-title":"Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2","volume":"137","author":"Huang","year":"2011","journal-title":"J Cancer Res Clin Oncol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3760\/cma.j.issn.0529-5815.2016.10.004","article-title":"[Effect of Sunitinib therapy on immune function of patients with advanced renal cell carcinoma]","volume":"54","author":"Xian","year":"2016","journal-title":"Zhonghua Wai Ke Za Zhi."},{"key":"B185","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00002371-200001000-00014","article-title":"Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapy","volume":"23","author":"Wiers","year":"2000","journal-title":"J Immunother."},{"key":"B186","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00262-003-0459-7","article-title":"Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3","volume":"53","author":"Lathers","year":"2004","journal-title":"Cancer Immunol Immunother."},{"key":"B187","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11523-018-0586-x","article-title":"Vitamin D deficiency has a negative impact on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells","volume":"13","author":"Mortara","year":"2018","journal-title":"Target Oncol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1111\/bph.13875","article-title":"Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF","volume":"174","author":"Merrigan","year":"2017","journal-title":"Br J Pharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"10111614","DOI":"10.3390\/nu10111614","article-title":"The role of vitamin E in immunity","volume":"10","author":"Lee","year":"2018","journal-title":"Nutrients."},{"key":"B190","doi-asserted-by":"publisher","first-page":"11021","DOI":"10.1158\/0008-5472.CAN-07-2593","article-title":"Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells","volume":"67","author":"Nefedova","year":"2007","journal-title":"Cancer Res."},{"key":"B191","doi-asserted-by":"publisher","first-page":"9299","DOI":"10.1158\/0008-5472.CAN-06-1690","article-title":"All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients","volume":"66","author":"Mirza","year":"2006","journal-title":"Cancer Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3978\/j.issn.2304-3881.2014.05.04","article-title":"The multifaceted nature of retinoid transport and metabolism","volume":"3","author":"Li","year":"2014","journal-title":"Hepatobiliary Surg Nutr."},{"key":"B193","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00262-013-1396-8","article-title":"Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer","volume":"62","author":"Iclozan","year":"2013","journal-title":"Cancer Immunol Immunother."},{"key":"B194","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1158\/0008-5472.CAN-17-3415","article-title":"Blockade of myeloid-derived suppressor cell expansion with all-trans retinoic acid increases the efficacy of antiangiogenic therapy","volume":"78","author":"Bauer","year":"2018","journal-title":"Cancer Res."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e0174555","DOI":"10.1371\/journal.pone.0174555","article-title":"All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits angiogenesis and metastasis in esophageal squamous cell carcinoma","volume":"12","author":"Li","year":"2017","journal-title":"PLoS ONE."},{"key":"B196","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ijc.10966","article-title":"Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid","volume":"104","author":"Jinushi","year":"2003","journal-title":"Int J Cancer."},{"key":"B197","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2006.10.132","article-title":"All-trans retinoic acid negatively regulates cytotoxic activities of nature killer cell line 92","volume":"352","author":"Li","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B198","first-page":"761","article-title":"In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-alpha alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression","volume":"17","author":"Konjevic","year":"2012","journal-title":"J BUON."},{"key":"B199","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res."},{"key":"B200","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1476-4598-9-217","article-title":"A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells","volume":"9","author":"Lin","year":"2010","journal-title":"Mol Cancer."},{"key":"B201","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1476-4598-9-165","article-title":"The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity","volume":"9","author":"Bill","year":"2010","journal-title":"Mol Cancer."},{"key":"B202","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/cbr.2012.1219","article-title":"Cucurbitacin B regulates immature myeloid cell differentiation and enhances antitumor immunity in patients with lung cancer","volume":"27","author":"Lu","year":"2012","journal-title":"Cancer Biother Radiopharm."},{"key":"B203","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00262-017-1966-2","article-title":"Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities","volume":"66","author":"Kortylewski","year":"2017","journal-title":"Cancer Immunol Immunother."},{"key":"B204","doi-asserted-by":"publisher","first-page":"e1230578","DOI":"10.1080\/2162402X.2016.1230578","article-title":"TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function","volume":"5","author":"Spinetti","year":"2016","journal-title":"Oncoimmunology."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1182\/blood-2015-08-665604","article-title":"Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood."},{"key":"B206","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-17-0741","article-title":"Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma","volume":"23","author":"Orillion","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B207","doi-asserted-by":"publisher","first-page":"11774","DOI":"10.1073\/pnas.1410626111","article-title":"Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells","volume":"111","author":"Kim","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B208","doi-asserted-by":"publisher","first-page":"e1466018","DOI":"10.1080\/2162402X.2018.1466018","article-title":"Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types","volume":"7","author":"Hicks","year":"2018","journal-title":"Oncoimmunology."},{"key":"B209","unstructured":"Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function2691702 SerafiniP MeckelK KelsoM NoonanK CalifanoJ KochW 10.1084\/jem.2006110417101732J Exp Med.2032006"},{"key":"B210","doi-asserted-by":"publisher","first-page":"17111","DOI":"10.1073\/pnas.1108121108","article-title":"Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model","volume":"108","author":"Meyer","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B211","unstructured":"Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC4152 LinS WangJ WangL WenJ GuoY QiaoW 28123846Am J Cancer Res.72017"},{"key":"B212","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-14-1716","article-title":"Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Califano","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B213","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/1078-0432.CCR-14-1711","article-title":"Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Weed","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B214","doi-asserted-by":"publisher","first-page":"e1326440","DOI":"10.1080\/2162402X.2017.1326440","article-title":"Tadalafil has biologic activity in human melanoma","volume":"6","author":"Hassel","year":"2017","journal-title":"Oncoimmunology"},{"key":"B215","unstructured":"Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer32530 HamiltonTK HuN KolomitroK BellEN MauriceDH GrahamCH 10.1007\/s00345-012-0848-722383129World J Urol.312013"},{"key":"B216","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.4049\/jimmunol.0803523","article-title":"Regulation of NK cell function by human granulocyte arginase","volume":"182","author":"Oberlies","year":"2009","journal-title":"J Immunol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fimmu.2017.00093","article-title":"Arginine metabolism in myeloid cells shapes innate and adaptive immunity","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front Immunol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"key":"B219","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature."},{"key":"B220","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodriguez","year":"2008","journal-title":"Immunol Rev."},{"key":"B221","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/bjs.1800840229","article-title":"Dietary supplementation with L-arginine: modulation of tumour-infiltrating lymphocytes in patients with colorectal cancer","volume":"84","author":"Heys","year":"1997","journal-title":"Br J Surg."},{"key":"B222","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/1471-2407-10-464","article-title":"COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma","volume":"10","author":"Veltman","year":"2010","journal-title":"BMC Cancer"},{"key":"B223","doi-asserted-by":"publisher","first-page":"36317","DOI":"10.18632\/oncotarget.26347","article-title":"Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer","volume":"9","author":"Kuroda","year":"2018","journal-title":"Oncotarget."},{"key":"B224","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00262-014-1561-8","article-title":"Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells","volume":"63","author":"Kosaka","year":"2014","journal-title":"Cancer Immunol Immunother."},{"key":"B225","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.3390\/molecules180910132","article-title":"Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells","volume":"18","author":"Iachininoto","year":"2013","journal-title":"Molecules."},{"key":"B226","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J Immunol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.yexcr.2014.09.008","article-title":"COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells","volume":"330","author":"Kim","year":"2015","journal-title":"Exp Cell Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"19041019","DOI":"10.3390\/ijms19041019","article-title":"EP4 as a therapeutic target for aggressive human breast cancer","volume":"19","author":"Majumder","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3389\/fimmu.2018.02499","article-title":"Reactive oxygen species as regulators of MDSC-mediated immune suppression","volume":"9","author":"Ohl","year":"2018","journal-title":"Front Immunol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1158\/1078-0432.CCR-09-3272","article-title":"Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer","volume":"16","author":"Nagaraj","year":"2010","journal-title":"Clin Cancer Res."},{"key":"B231","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2147\/DDDT.S68872","article-title":"Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Des Devel Ther."},{"key":"B232","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.celrep.2014.03.073","article-title":"Interleukin-17D mediates tumor rejection through recruitment of natural killer cells","volume":"7","author":"O'Sullivan","year":"2014","journal-title":"Cell Rep."},{"key":"B233","doi-asserted-by":"publisher","first-page":"e954853","DOI":"10.4161\/21624011.2014.954853","article-title":"Tumor-expressed IL-17D recruits NK cells to reject tumors","volume":"3","author":"Saddawi-Konefka","year":"2014","journal-title":"Oncoimmunology."},{"key":"B234","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.celrep.2016.07.075","volume":"16","author":"Saddawi-Konefka","year":"2016","journal-title":"Cell Rep."},{"key":"B235","doi-asserted-by":"publisher","first-page":"13670","DOI":"10.1038\/s41598-018-32011-2","article-title":"Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection","volume":"8","author":"Seelige","year":"2018","journal-title":"Sci Rep."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.jid.2017.03.033","article-title":"Phenformin inhibits myeloid-derived suppressor cells and enhances the anti-tumor activity of PD-1 blockade in melanoma","volume":"137","author":"Kim","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"e1442167","DOI":"10.1080\/2162402X.2018.1442167","article-title":"Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis","volume":"7","author":"Qin","year":"2018","journal-title":"Oncoimmunology."},{"key":"B238","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/intimm\/dxy079","article-title":"Metformin induces CD11b+ cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and antitumor effects","volume":"31","author":"Uehara","year":"2018","journal-title":"Int Immunol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.radonc.2018.04.003","article-title":"Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer","volume":"127","author":"de Mey","year":"2018","journal-title":"Radiother Oncol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/0008-5472.CAN-17-2460","article-title":"Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res."},{"key":"B241","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"B242","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000448175","article-title":"Metformin and angiogenesis in cancer\u2014revisited","volume":"91","author":"Kannarkatt","year":"2016","journal-title":"Oncology."},{"key":"B243","doi-asserted-by":"publisher","first-page":"E534","DOI":"10.1002\/ijc.29193","article-title":"The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells","volume":"136","author":"Orecchioni","year":"2015","journal-title":"Int J Cancer."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/carcin\/bgu001","article-title":"Paradoxic effects of metformin on endothelial cells and angiogenesis","volume":"35","author":"Dallaglio","year":"2014","journal-title":"Carcinogenesis."},{"key":"B245","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol Cell."},{"key":"B246","doi-asserted-by":"publisher","first-page":"25808","DOI":"10.18632\/oncotarget.25380","article-title":"Metformin exerts antitumor activity via inductionof multiple death pathways in tumor cells and activation of a protective immune response","volume":"9","author":"Pereira","year":"2018","journal-title":"Oncotarget."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B248","doi-asserted-by":"publisher","first-page":"27252","DOI":"10.18632\/oncotarget.4583","article-title":"TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression","volume":"6","author":"Ho","year":"2015","journal-title":"Oncotarget."},{"key":"B249","first-page":"4385","article-title":"Functional alteration of tumor-infiltrating myeloid cells in RNA adjuvant therapy","volume":"35","author":"Seya","year":"2015","journal-title":"Anticancer Res."},{"key":"B250","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000355126","article-title":"Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models","volume":"6","author":"Shime","year":"2014","journal-title":"J Innate Immun."},{"key":"B251","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clim.2016.01.014","article-title":"Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling","volume":"164","author":"Pang","year":"2016","journal-title":"Clin Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:14:08Z","timestamp":1694812448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":251,"alternative-id":["10.3389\/fimmu.2019.00771"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00771","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"article-number":"771"}}